- 入驻时间: 2012-04-17
- 联系人:客户经理
- 电话:400-968-7988
-
联系时,请说明易展网看到的
- Email:fuwu@bioleaf.com
产品介绍 |
|||
品名 |
Monoclonal Antibody to Human Factor B (Ba) |
||
货号 |
A225 |
||
规格 |
100 µL |
||
同种型 |
IgG1k |
||
蛋白质浓度 | > 1.0 mg/mL | ||
缓冲液 |
≥ 95% by SDS PAGE |
||
物种交叉反应 |
None tested |
||
储存 |
≤ 30 Days 2-8˚C > 30 Days ≤ –20˚C |
||
使用说明 |
For Research Use Only. Not for use in diagnostic procedures |
||
产品描述 |
Factor B is one of the complement proteins which is unique to the Alternative Pathway. It is a single-chain glycoprotein with a molecular weight of approximately 98 kD. The concentration of Factor B in human serum/plasma is ~200 μg/ml.
The Alternative Complement Pathway provides innate protection against microbial agents in the absence of specific antibodies. The activation of this complement pathway can be triggered by a variety of substances, including microbial polysaccharaides or lipids, gram-negative bacterial lipopolysaccharides, and surface determinants present on some viruses, parasites, virally infected mammalian cells, and cancer cells. In autoimmune diseases, the Alternative Complement Pathway may contribute directly to tissue damage. |
||
特异性 |
The specificity of the monoclonal antibody for the Factor B (Ba) protein was established by ELISA. The antibody was shown to bind highly purified Factor B and its Ba fragment, but not to the Bb fragment. The antibody binds a non-neoantigen in the Ba domain of native Factor B, since highly purified, functionally active Factor B and normal human plasma blocked binding of the antibody to both Factor B and Ba fragments coated in microtiter wells. Zymosan activated human serum was not more effective than the corresponding non-activated plasma in blocking the binding of this antibody. |
||
应用 |
![]() |